TY  - GEN
AU  - Liou,Jyh-Ming
AU  - Chen,Chieh-Chang
AU  - Fang,Yu-Jen
AU  - Chen,Po-Yueh
AU  - Chang,Chi-Yang
AU  - Chou,Chu-Kuang
AU  - Chen,Mei-Jyh
AU  - Tseng,Cheng-Hao
AU  - Lee,Ji-Yuh
AU  - Yang,Tsung-Hua
AU  - Chiu,Min-Chin
AU  - Yu,Jian-Jyun
AU  - Kuo,Chia-Chi
AU  - Luo,Jiing-Chyuan
AU  - Hsu,Wen-Feng
AU  - Hu,Wen-Hao
AU  - Tsai,Min-Horn
AU  - Lin,Jaw-Town
AU  - Shun,Chia-Tung
AU  - Twu,Gary
AU  - Lee,Yi-Chia
AU  - Bair,Ming-Jong
AU  - Wu,Ming-Shiang
TI  - 14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial
SN  - 1460-2091
PY  - 2019///1008
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antacids
KW  - administration & dosage
KW  - Anti-Bacterial Agents
KW  - Anti-Ulcer Agents
KW  - Bismuth
KW  - Drug Therapy, Combination
KW  - adverse effects
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Esomeprazole
KW  - Helicobacter Infections
KW  - drug therapy
KW  - Helicobacter pylori
KW  - isolation & purification
KW  - Humans
KW  - Middle Aged
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/jac/dky183
ER  -